Sign In
Buy NTRA
$318.35
-3.75 (-1.16%)
At Close: Aug 10, 2026
Natera, Inc. (NASDAQ:NTRA) Receives Average Rating of “Moderate Buy” from Analysts
01:58am, Friday, 27'th Feb 2026
Natera, Inc. (NASDAQ: NTRA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eighteen analysts that are presently covering the firm, MarketBeat.com reports. One rese
Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
09:37pm, Thursday, 26'th Feb 2026
Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
Natera (NTRA) Tops Q4 Earnings and Revenue Estimates
07:46pm, Thursday, 26'th Feb 2026
Natera (NTRA) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.46 per share. This compares to a loss of $0.41 per share a year ago.
Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:30pm, Thursday, 26'th Feb 2026
The headline numbers for Natera (NTRA) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors
07:05pm, Thursday, 26'th Feb 2026
Investor attention turned more intensely to the scale, timing, and funding of AI-related capital commitments, prompting renewed debate about whether expectations were running ahead of eventual monetiz
Natera Reports Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Thursday, 26'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended Decem
Fox Run Management L.L.C. Buys 3,491 Shares of Natera, Inc. $NTRA
05:08am, Wednesday, 25'th Feb 2026
Fox Run Management L.L.C. boosted its stake in Natera, Inc. (NASDAQ: NTRA) by 42.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. T
Alger SICAV - Alger Dynamic Opportunities Fund Q4 2025 Portfolio Update
02:16pm, Tuesday, 24'th Feb 2026
For the quarter, Alger SICAV - Alger Dynamic Opportunities Fund portfolio's average long exposure was 80.88% and the average short exposure was -32.28%. Long positions MongoDB, Inc., Natera, Inc., and
Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
06:00am, Tuesday, 24'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the SINERGY trial, a Phase 2 study in recurrent or me
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics
10:16am, Monday, 23'rd Feb 2026
Beyond analysts' top-and-bottom-line estimates for Natera (NTRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Billionaire Stanley Druckenmiller Is Betting Big on These 2 Stocks
07:30pm, Saturday, 21'st Feb 2026
One investment is a fast-growing genetic testing company that's now generating cash flow and has a scalable business model. The leading semiconductor foundry's sales are booming on AI-led demand, but
Natera, Inc. $NTRA Shares Purchased by State of New Jersey Common Pension Fund D
04:14am, Wednesday, 18'th Feb 2026
State of New Jersey Common Pension Fund D increased its stake in shares of Natera, Inc. (NASDAQ: NTRA) by 5.7% during the third quarter, according to the company in its most recent disclosure with the
Philippe Laffont's Strategic Exit from CoreWeave Inc: A -2.26% Portfolio Impact
06:18pm, Tuesday, 17'th Feb 2026
Insights into Philippe Laffont (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Philippe Laffont (Trades, Portfolio) recently submitted the 13F filin
Alger Mid Cap Growth Fund Q4 2025 Portfolio Update
01:25pm, Tuesday, 17'th Feb 2026
Class A shares of the Alger Mid Cap Growth Fund outperformed the Russell Midcap Growth Index during the fourth quarter of 2025. Cidara Therapeutics, Inc., Natera, Inc., and Abivax were among the top c
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
09:00am, Tuesday, 17'th Feb 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended De
